ReviewNutrients2026
Beneficial Roles of Bioconversion-Derived Metabolites of Dietary Components as Potential Biological Regulators in Obesity and Type 2 Diabetes Mellitus.
Review in Nutrients, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
Obesity and type 2 diabetes are associated with alterations in gut microbial composition and host nutrient metabolism, both of which can modify the bioconversion of dietary compounds. Consequently, identical dietary substrates may generate distinct metabolite profiles, leading to different physiological responses. Emerging evidence suggests that many biological effects of dietary compounds are mediated, in part, by metabolites generated through host and microbial bioconversion. These metabolites regulate key pathways involved in oxidative stress, inflammatory signaling, glucose metabolism, and gut barrier integrity. Altered bioconversion efficiency observed in obesity and type 2 diabetes may therefore influence metabolic outcomes by altering the quantity and composition of bioactive metabolites. This review summarizes current evidence on the metabolic effects of bioconversion-derived metabolites generated from dietary components and discusses their underlying molecular mechanisms in obesity and type 2 diabetes. By focusing on metabolites generated through dietary bioconversion rather than dietary substrates alone, this review proposes a metabolite-centered framework for understanding variability in dietary responses and identifying metabolically relevant targets for future nutritional interventions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.